Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression
- PMID: 22303844
- DOI: 10.3109/1061186X.2012.655247
Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression
Abstract
The delivery of nucleic acid molecules into cells to alter physiological functions at the genetic level is a powerful approach to treat a wide range of inherited and acquired disorders. Biocompatible materials such as cationic polymers, lipids, and peptides are being explored as safer alternatives to viral gene carriers. However, the comparatively low efficiency of nonviral carriers currently hampers their translation into clinical settings. Controlling the size and stability of carrier/nucleic acid complexes is one of the primary hurdles as the physicochemical properties of the complexes can define the uptake pathways, which dictate intracellular routing, endosomal processing, and nucleocytoplasmic transport. In addition to nuclear import, subnuclear trafficking, posttranscriptional events, and immune responses can further limit transfection efficiency. Chemical moieties, reactive linkers or signal peptide have been conjugated to carriers to prevent aggregation, induce membrane destabilization and localize to subcellular compartments. Genetic elements can be inserted into the expression cassette to facilitate nuclear targeting, delimit expression to targeted tissue, and modulate transgene expression. The modular option afforded by both gene carriers and expression cassettes provides a two-tier multicomponent delivery system that can be optimized for targeted gene delivery in a variety of settings.
Similar articles
-
Analysis of the intracellular barriers encountered by nonviral gene carriers in a model of spatially controlled delivery to neurons.J Gene Med. 2008 Feb;10(2):187-97. doi: 10.1002/jgm.1137. J Gene Med. 2008. PMID: 18064730
-
Peptide vectors for the nonviral delivery of nucleic acids.Acc Chem Res. 2012 Jul 17;45(7):1048-56. doi: 10.1021/ar2002304. Epub 2012 Mar 28. Acc Chem Res. 2012. PMID: 22455499
-
Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery.Pharmacol Rev. 2006 Mar;58(1):32-45. doi: 10.1124/pr.58.1.8. Pharmacol Rev. 2006. PMID: 16507881 Review.
-
Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.J Control Release. 2010 Jan 4;141(1):42-51. doi: 10.1016/j.jconrel.2009.08.028. Epub 2009 Sep 8. J Control Release. 2010. PMID: 19744531
-
To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?Hum Gene Ther. 2011 Jul;22(7):799-807. doi: 10.1089/hum.2011.065. Epub 2011 Jun 17. Hum Gene Ther. 2011. PMID: 21563983 Review.
Cited by
-
An Integrated Approach toward the Biomanufacturing of Engineered Cell Therapy Products in a Stirred-Suspension Bioreactor.Mol Ther Methods Clin Dev. 2018 Apr 27;9:376-389. doi: 10.1016/j.omtm.2018.04.007. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2018. PMID: 30038941 Free PMC article.
-
High Throughput and Highly Controllable Methods for In Vitro Intracellular Delivery.Small. 2020 Dec;16(51):e2004917. doi: 10.1002/smll.202004917. Epub 2020 Nov 25. Small. 2020. PMID: 33241661 Free PMC article. Review.
-
Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance.Front Bioeng Biotechnol. 2020 Nov 26;8:599674. doi: 10.3389/fbioe.2020.599674. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 33324625 Free PMC article. Review.
-
Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.Molecules. 2017 Oct 13;22(10):1724. doi: 10.3390/molecules22101724. Molecules. 2017. PMID: 29027965 Free PMC article. Review.
-
Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment.PLoS One. 2020 Dec 21;15(12):e0244386. doi: 10.1371/journal.pone.0244386. eCollection 2020. PLoS One. 2020. PMID: 33347482 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical